These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33458928)

  • 21. Co-supplementation of isomalto-oligosaccharides potentiates metabolic health benefits of polyphenol-rich cranberry extract in high fat diet-fed mice via enhanced gut butyrate production.
    Singh DP; Singh S; Bijalwan V; Kumar V; Khare P; Baboota RK; Singh P; Boparai RK; Singh J; Kondepudi KK; Chopra K; Bishnoi M
    Eur J Nutr; 2018 Dec; 57(8):2897-2911. PubMed ID: 29127476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the Human Gut Microbiome of Urolithin Metabotypes: Association with Enterotypes and Potential Cardiometabolic Health Implications.
    Romo-Vaquero M; Cortés-Martín A; Loria-Kohen V; Ramírez-de-Molina A; García-Mantrana I; Collado MC; Espín JC; Selma MV
    Mol Nutr Food Res; 2019 Feb; 63(4):e1800958. PubMed ID: 30471188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diets naturally rich in polyphenols and/or long-chain n-3 polyunsaturated fatty acids differently affect microbiota composition in high-cardiometabolic-risk individuals.
    Vetrani C; Maukonen J; Bozzetto L; Della Pepa G; Vitale M; Costabile G; Riccardi G; Rivellese AA; Saarela M; Annuzzi G
    Acta Diabetol; 2020 Jul; 57(7):853-860. PubMed ID: 32114641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex Differences in the Gut Microbiota as Potential Determinants of Gender Predisposition to Disease.
    Santos-Marcos JA; Haro C; Vega-Rojas A; Alcala-Diaz JF; Molina-Abril H; Leon-Acuña A; Lopez-Moreno J; Landa BB; Tena-Sempere M; Perez-Martinez P; Lopez-Miranda J; Perez-Jimenez F; Camargo A
    Mol Nutr Food Res; 2019 Apr; 63(7):e1800870. PubMed ID: 30636111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arabinoxylan oligosaccharides and polyunsaturated fatty acid effects on gut microbiota and metabolic markers in overweight individuals with signs of metabolic syndrome: A randomized cross-over trial.
    Kjølbæk L; Benítez-Páez A; Gómez Del Pulgar EM; Brahe LK; Liebisch G; Matysik S; Rampelli S; Vermeiren J; Brigidi P; Larsen LH; Astrup A; Sanz Y
    Clin Nutr; 2020 Jan; 39(1):67-79. PubMed ID: 30827722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential use of seaweed polysaccharides as prebiotics for management of metabolic syndrome: a review.
    Wang S; Zhang B; Chang X; Zhao H; Zhang H; Zhao T; Qi H
    Crit Rev Food Sci Nutr; 2024; 64(22):7707-7727. PubMed ID: 36971135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism.
    Zeng SL; Li SZ; Xiao PT; Cai YY; Chu C; Chen BZ; Li P; Li J; Liu EH
    Sci Adv; 2020 Jan; 6(1):eaax6208. PubMed ID: 31922003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial Effects of Phenolic Compounds on Gut Microbiota and Metabolic Syndrome.
    Kasprzak-Drozd K; Oniszczuk T; Stasiak M; Oniszczuk A
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of gut microbiota and its response to a Chinese Herbal Formula in elder patients with metabolic syndrome.
    Ni Y; Mu C; He X; Zheng K; Guo H; Zhu W
    Drug Discov Ther; 2018; 12(3):161-169. PubMed ID: 29998997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prebiotic UG1601 mitigates constipation-related events in association with gut microbiota: A randomized placebo-controlled intervention study.
    Chu JR; Kang SY; Kim SE; Lee SJ; Lee YC; Sung MK
    World J Gastroenterol; 2019 Oct; 25(40):6129-6144. PubMed ID: 31686768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of habitual dietary fibre intake on the responsiveness of the gut microbiota to a prebiotic: protocol for a randomised, double-blind, placebo-controlled, cross-over, single-centre study.
    Healey G; Brough L; Butts C; Murphy R; Whelan K; Coad J
    BMJ Open; 2016 Sep; 6(9):e012504. PubMed ID: 27591024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Beneficial Effects of Lippia Citriodora Extract on Diet-Induced Obesity in Mice Are Associated with Modulation in the Gut Microbiota Composition.
    Diez-Echave P; Vezza T; Rodríguez-Nogales A; Hidalgo-Garcia L; Garrido-Mesa J; Ruiz-Malagon A; Molina-Tijeras JA; Romero M; Robles-Vera I; Leyva-Jiménez FJ; Lozano-Sanchez J; Arráez-Román D; Segura-Carretero A; Micol V; García F; Morón R; Duarte J; Rodríguez-Cabezas ME; Gálvez J
    Mol Nutr Food Res; 2020 Jul; 64(13):e2000005. PubMed ID: 32415899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary pomegranate extract and inulin affect gut microbiome differentially in mice fed an obesogenic diet.
    Zhang S; Yang J; Henning SM; Lee R; Hsu M; Grojean E; Pisegna R; Ly A; Heber D; Li Z
    Anaerobe; 2017 Dec; 48():184-193. PubMed ID: 28870713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome.
    de Cossío LF; Fourrier C; Sauvant J; Everard A; Capuron L; Cani PD; Layé S; Castanon N
    Brain Behav Immun; 2017 Aug; 64():33-49. PubMed ID: 28027925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oat bran, but not its isolated bioactive β-glucans or polyphenols, have a bifidogenic effect in an in vitro fermentation model of the gut microbiota.
    Kristek A; Wiese M; Heuer P; Kosik O; Schär MY; Soycan G; Alsharif S; Kuhnle GGC; Walton G; Spencer JPE
    Br J Nutr; 2019 Mar; 121(5):549-559. PubMed ID: 30688188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of wheat bran derived prebiotic supplementation on gastrointestinal transit, gut microbiota, and metabolic health: a randomized controlled trial in healthy adults with a slow gut transit.
    Müller M; Hermes GDA; Emanuel E C; Holst JJ; Zoetendal EG; Smidt H; Troost F; Schaap FG; Damink SO; Jocken JWE; Lenaerts K; Masclee AAM; Blaak EE
    Gut Microbes; 2020 Nov; 12(1):1704141. PubMed ID: 31983281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Where to Look into the Puzzle of Polyphenols and Health? The Postbiotics and Gut Microbiota Associated with Human Metabotypes.
    Cortés-Martín A; Selma MV; Tomás-Barberán FA; González-Sarrías A; Espín JC
    Mol Nutr Food Res; 2020 May; 64(9):e1900952. PubMed ID: 32196920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
    Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
    Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Link between gut microbiota and health outcomes in inulin -treated obese patients: Lessons from the Food4Gut multicenter randomized placebo-controlled trial.
    Hiel S; Gianfrancesco MA; Rodriguez J; Portheault D; Leyrolle Q; Bindels LB; Gomes da Silveira Cauduro C; Mulders MDGH; Zamariola G; Azzi AS; Kalala G; Pachikian BD; Amadieu C; Neyrinck AM; Loumaye A; Cani PD; Lanthier N; Trefois P; Klein O; Luminet O; Bindelle J; Paquot N; Cnop M; Thissen JP; Delzenne NM
    Clin Nutr; 2020 Dec; 39(12):3618-3628. PubMed ID: 32340903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.